Bitcoin price today: gains to $120k, near record high on U.S. regulatory cheer
Robert M. Williams Jr., a significant shareholder of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), has sold 750,000 shares of the company’s common stock. The shares were sold at a price of $5.20 each, totaling approximately $3.9 million. The transaction comes as AVAH shares have delivered a remarkable 106% return over the past year, with the stock currently trading at $5.11, giving the company a market capitalization of approximately $1.05 billion.
Following this transaction on June 10, Williams retains indirect ownership of 28,890,756 shares through various entities, as indicated in the SEC filing. Williams, who is affiliated with J.H. Whitney Capital Partners (WA:CPAP), is not an officer or director of the company but is a ten percent owner. According to InvestingPro, analysts maintain price targets ranging from $5 to $7 for AVAH, and the company maintains a GOOD financial health score.
This sale reflects a strategic decision by Williams and his associated entities, which maintain substantial holdings in Aveanna Healthcare. For deeper insights into AVAH’s valuation and growth prospects, InvestingPro offers additional analysis and metrics in its comprehensive Pro Research Report.
In other recent news, Aveanna Healthcare Holdings Inc. announced impressive first-quarter results for 2025, exceeding analysts’ expectations. The company reported earnings per share of $0.10, surpassing the anticipated loss of $0.0014, and revenue of $559 million, which was higher than the forecasted $513.7 million. Aveanna has projected its annual revenue to exceed $2.15 billion, indicating strong future growth expectations. Additionally, the company’s adjusted EBITDA rose significantly by 93.1% year-over-year to $67.4 million, driven by substantial growth in key segments such as Private Duty Services.
In terms of mergers and acquisitions, Aveanna is on track to complete its acquisition of ThriveSkilled Pediatrics, which is expected to enhance its preferred payer and government affairs strategies. This acquisition aligns with the company’s strategic priorities and is anticipated to contribute positively to its operations. Furthermore, Aveanna’s recent annual meeting saw stockholders ratify the election of directors and the appointment of Ernst & Young LLP as the independent auditor.
Analyst firms such as Jefferies and Deutsche Bank (ETR:DBKGn) have shown interest in Aveanna’s strategic initiatives and financial performance, particularly in its efforts to improve reimbursement rates and expand preferred payer agreements. These developments reflect Aveanna’s ongoing commitment to strategic growth and financial stability.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.